I wasn’t pleased with what seemed to be some selective disclosure, if that was, in fact, the case. I was not on the call. I do own AstraZeneca in the fund for reasons unrelated to the COVID-19 vaccine. Ironically, it relates to their current drugs in their pipeline. But one never wants to see selective disclosure involved for any client base. Having said that, now that we are learning more about this disclosure, about the condition that led to the pause of the drug trial, you’ve had experience with vaccine trials before. How worrisome is this… for all us, hoping for a vaccine, sooner than later? Well, I think what history shows is that vaccines sometimes don’t work.
AstraZeneca Made a Bone-Headed Decision to Not Be Transparent With American Public: Chris Meekins
Published September 14, 2020 | Best in Video